Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk.
Brennan K, García-Closas M, Orr N, Fletcher O, Jones M, Ashworth A, Swerdlow A, Thorne H, kConFab Investigators kConFab Investigators, Riboli E, Vineis P, Dorronsoro M, Clavel-Chapelon F, Panico S, Onland-Moret NC, Trichopoulos D, Kaaks R, Khaw KT, Brown R, Flanagan JM
Cancer research. Mar 2012
(DOI : 10.1158/0008-5472.CAN-11-3157)